Susan Hasty, Publisher
Table of Contents . . . July 24th, 1995Non-Subscriber - Summaries Only
Cancer Vaccines - Human Carcinoembryonic Antigen as Second-Generation Immunotherapy
Breast Cancer/Risk - Hormone Replacement Therapy Not Linked to Increased Risk
Immunological Research - Eliminating Factors Necessary for Tumor Growth Stimulates Rejection
Immunological Research - Process Provides Ability to Screen Cancer Patients for Anti-Tumor Antibodies
Malignant Mesothelioma - Gene Therapy May Be Effective Against Cancer That Affects Lungs
Therapy/Cord Blood - Stem Cells Show Promise for Both Transplantation and Gene Therapy
Transfusion/Blood Filtration - Experts Recommend Leukocyte Depletion Should Be Standard
Transplantation/Acute Myeloid Leukemia - Simvastatin Is a Potential Purging Agent for Autologous BMT
Virology/HTLV-I - Some Carriers May Have Seronegative Test Results
Disease Associations - "HTLV-I and Aboriginal Health."
Immunology - "Suppression of Tumorigenesis by Transcription Units Expressing the Antisense E6 and E7 mRNA for the Transforming Proteins of the HPV 18 and the Sense mRNA for the Retinoblastoma (Rb) Gene in Cervical Carcinoma Cells. DOU
B-Cell Tumors - Immunotherapy - "Eradication of Large Human B Cell Tumors in Nude Mice with Unconjugated CD20 Monoclonal Antibodies and Interleukin 2."
Drug Delivery - "Identification of a Monoclonal Antibody, TV-1, Directed Against the Basement Membrane of Tumor Vessels, and Its Use to Enhance the Delivery of Macromolecules to Tumors After Conjugation with interleukin
Neurotoxicity - "Cisplatin-Associated Neurotoxicity: Can It Be Prevented?."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.